help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2005-1606
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rendina, D.
Right arrow Articles by Strazzullo, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rendina, D.
Right arrow Articles by Strazzullo, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*1,25-DIHYDROXYCHOLECALCIFEROL
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Related Collections
Right arrow Calcium and Bone Metabolism
The Journal of Clinical Endocrinology & Metabolism Vol. 91, No. 3 959-963
Copyright © 2006 by The Endocrine Society


BRIEF REPORT

Fibroblast Growth Factor 23 Is Increased in Calcium Nephrolithiasis with Hypophosphatemia and Renal Phosphate Leak

Domenico Rendina, Giuseppe Mossetti, Gianpaolo De Filippo, Michele Cioffi and Pasquale Strazzullo

Department of Clinical and Experimental Medicine (D.R., G.M., P.S.), Federico II University Medical School, 80131 Naples, Italy; Unit of Pediatric Endocrinology (G.D.F.), Azienda Ospedaliera di Rilievo Nazionale "G. Rummo," 82100 Benevento, Italy; and Department of General Pathology (M.C.), Second University of Naples, 80121 Naples, Italy

Address all correspondence and requests for reprints to: Giuseppe Mossetti, Dipartimento di Medicina Clinica e Sperimentale, Università Federico II, Via S. Pansini, 5-80131 Naples, Italy. E-mail: giumosse{at}unina.it.

Context: Nephrolithiasis affects about 10% of the population in industrialized countries, with calcium salts composing more than 80% of renal stones. A significant percentage of patients with calcium nephrolithiasis and normal parathyroid function show hypophosphatemia and reduced renal phosphate reabsorption (i.e. a renal phosphate leak).

Objectives: The objective of the study was to compare serum levels of fibroblast growth factor 23 (FGF23), a regulator of phosphate homeostasis, in 110 recurrent stone formers with or without renal phosphate leak, six patients affected by X-linked hypophosphatemic rickets, five patients affected by oncogenic osteomalacia, and 60 unrelated healthy controls.

Design: This was a prospective interventional study.

Methods: Renal phosphate leak was identified based on the occurrence of idiopathic hypophosphatemia [serum phosphate concentration < 2.50 mg/dl (<0.80 mmol/liter)] and reduced renal threshold phosphate concentration [<2.2 mg/liter (<0.70 mmol/liter)].

Results: In 22 stone formers with renal phosphate leak, serum FGF23 concentration was significantly higher as compared with 88 stone formers without renal phosphate leak and with controls [83.3 (65.6–101.1) vs. 32.1 (26.8–37.4) and 24.5 (19.8–29.1) reference units (RU)/ml, respectively]. Stone formers with renal phosphate leak showed lower FGF23, compared with patients with oncogenic osteomalacia and X-linked hypophosphatemic rickets [572.3 (235.9–908.7) RU/ml]. Among stone formers and controls, serum FGF23 concentration displayed a strong inverse association with serum phosphate (r = –0.784, P = 0.009) and the rate of tubular phosphate reabsorption (r = –0.791, P = 0.008).

Conclusions: In our study population, renal phosphate leak affected 20% of stone formers and was strongly associated with increased serum FGF23 concentration.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
A. L. Tencza, S. Ichikawa, A. Dang, D. Kenagy, E. McCarthy, M. J. Econs, and M. A. Levine
Hypophosphatemic Rickets with Hypercalciuria due to Mutation in SLC34A3/Type IIc Sodium-Phosphate Cotransporter: Presentation as Hypercalciuria and Nephrolithiasis
J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4433 - 4438.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
B. S. Levine, C. R. Kleeman, and A. J. Felsenfeld
The Journey From Vitamin D-Resistant Rickets to the Regulation of Renal Phosphate Transport
Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1866 - 1877.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. Bergwitz, M. Bastepe, D. Rendina, G. De Filippo, P. Strazzullo, D. Prie, and G. Friedlander
NHERF1 Mutations and Responsiveness of Renal Parathyroid Hormone
N. Engl. J. Med., December 11, 2008; 359(24): 2615 - 2617.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society